Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 84

Sort by

Sort Order Select

Journal Articles

Multicenter Real-World Use of Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma(DLBCL) of Frontline and Relapse/Refractory Settings in China

Zhangyuting He, Huiying Zhu, Chong Wei, Danqing Zhao, Wei Wang, Jian Li, Wei Zhang, Daobin Zhou, Yan Zhang

Blood (2024) 144 (Supplement 1): 6504.

https://doi.org/10.1182/blood-2024-203008

Published: 2024

Journal Articles

Chemo-Free Salvage Treatment Is Better Than Traditional Chemotherapy in Relapsed/Refractory Subcutaneous Panniculitis-like T-Cell Lymphoma

Chao Chen, Jingjing Yin, Minghui Duan, Chong Wei, Congwei Jia, Wei Zhang, Jian Li, Daobin Zhou, Yan Zhang

Blood (2024) 144 (Supplement 1): 6400.

https://doi.org/10.1182/blood-2024-203578

Published: 2024

Journal Articles

CHOP Is Insufficient for Newly-Diagnosed Subcutaneous Panniculitis-like T-Cell Lymphoma Patients: A Retrospective Study of 32 Patients in China

Chao Chen, Jingjing Yin, Wei Wang, Danqing Zhao, Chong Wei, Cong-Wei Jia, Wei Zhang, Jian Li, Daobin Zhou, Yan Zhang

Blood (2024) 144 (Supplement 1): 6395.

https://doi.org/10.1182/blood-2024-202966

Published: 2024

Journal Articles

A Novel Direct Hemoglobin S Polymerization Inhibitor for the Treatment of Sickle Cell Disease - In Vivo Efficacy of Ilx-002 in Humanized Mice

Osheiza Abdulmalik, Kandace Gollomp, Veronica Bochenek, Conroy O Field, Mariana Macias, Benita Balogun, Salma Roland, Martin K Safo, Yan Zhang, Akua Donkor, Abdelsattar Omar, Moustafa El-Araby, David R. Light, Clark Brown, Andrew N Fleischman

Blood (2024) 144 (Supplement 1): 173.

https://doi.org/10.1182/blood-2024-202714

Published: 2024

Journal Articles

Rapid, Efficient and Durable Fetal Hemoglobin Production Following CS-101 Treatment in Transfusion-Dependent β-Thalassemia Participants: An Autologous, Ex Vivo Edited CD34+ Stem Cell Product Using the Innovative Transformer Base Editor (tBE)

Yongrong Lai, Rongrong Liu, Lijie Wang, Xu-Kai Ma, Yaliang Li, Gaohui Yang, Lingling Shi, Jia Wei, Zhenbin Wei, Xuemei Zhou, Kewei Lan, Yan Zhang, Xiaodun (Susan) Mou, Li Yang, Jia Chen

Blood (2024) 144 (Supplement 1): 4962.

https://doi.org/10.1182/blood-2024-200691

Published: 2024

Journal Articles

Polatuzumab Vedotin, Rituximab and Lenalidomide (Pola-R 2 ) As First-Line Therapy for Unfit and Frail Elderly Diffuse Large B-Cell Lymphoma Patients: Preliminary Result of a Prospective, Phase II, Multi-Center Study

Wei Wang, Xu Zhang, Qihui Li, Hua Yin, Xiubin Xiao, Jian Li, Wenrong Huang, Hongmei Jing, Yan Zhang

Blood (2024) 144 (Supplement 1): 1728.

https://doi.org/10.1182/blood-2024-198294

Published: 2024

Journal Articles

The Clinical Characteristics and Prognostic Analysis of Prolonged Cytopenia after CAR-T Cell Therapy

Huiying Zhu, Danqing Zhao, Zhe Zhuang, Chao Chen, Wei Zhang, Daobin Zhou, Jian Li, Yan Zhang

Blood (2024) 144 (Supplement 1): 7148.

https://doi.org/10.1182/blood-2024-207024

Published: 2024

Journal Articles

Prediction of Organs Toxicity during CAR T-Cell Therapy By Using Cell-Free DNA Markers

Liting Chen, Qiyang Han, Yan Zhang, Guodan Zeng, Yuekun Fang, Man Zhang, Jia Wei, Yicheng Zhang

Blood (2024) 144 (Supplement 1): 4782.

https://doi.org/10.1182/blood-2024-194685

Published: 2024

Journal Articles

Safety and Efficacy in Patients with Advanced Lymphomas from a Global Phase 1a/1b, First-in-Human Study of CS5001, a Novel Anti-ROR1 ADC

Blood (2024) 144 (Supplement 1): 1739.

https://doi.org/10.1182/blood-2024-192979

Published: 2024

Journal Articles

MBS314, a G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) x B-Cell Maturation Antigen (BCMA) x CD3 Trispecific Antibody, in Relapsed and/or Refractory Multiple Myeloma (RRMM): Preliminary Results from a Phase Ⅰ, First-in-Human, Open-Label, Dose Escalation Study

Gang An, Lijie Xing, Wenming Chen, Yan Zhang, Wen Gao, Lu-Gui Qiu, Guojin Wu, Jinying Ning, Min Wei, Feng Li

Blood (2024) 144 (Supplement 1): 3356.

https://doi.org/10.1182/blood-2024-199423

Published: 2024

Journal Articles

Inhibition of TGF-β in Bone Marrow Endothelial Progenitor Cells Promotes Hematopoietic Recovery in Acute Myeloid Leukemia after Chemotherapy

Zhenkun Wang, Zhi-Wei Zhang, Zhong-Shi Lyu, Tong Xing, Mi Liang, Mengzhu Shen, Chen-Yuan Li, Xin-Yan Zhang, Dan-Dan Chen, Ya-Zhe Wang, Li-Juan Hu, Hao Jiang, Qian Jiang, Yuan Kong, Xiao-Jun Huang

Blood (2024) 144 (Supplement 1): 2684.

https://doi.org/10.1182/blood-2024-201354

Published: 2024

Journal Articles

Foxo1 is an iron-responsive transcriptional factor regulating systemic iron homeostasis

Teng Xu, Xu Zhang, Wenting Zhao, Jiaxin Shi, Sitong Wan, Yan Zhang, Yanling Hao, Mingyue Sun, Jingjing He, Li Jiang, Hao Wang, Hong Gao, Junjie Luo, Yongting Luo, Peng An

Blood (2024) 144 (12): 1314–1328.

https://doi.org/10.1182/blood.2024024293

Published: 2024

Includes: Supplemental data

Journal Articles

T/B MPAL with MLLT10 :: ASUN fusion

Yan Zhang, Pingping Wang

Blood (2024) 143 (23): 2438.

https://doi.org/10.1182/blood.2024024033

Published: 2024

Journal Articles

VLA-4 Agonist Enhances the Capacity of HSC Engraftment and Immune Reconstitution

Xianmin Song, Qiaomei He, Xi Sun, Fang Zhang, Pengran Wang, Yan Zhang

Blood (2023) 142 (Supplement 1): 2705.

https://doi.org/10.1182/blood-2023-184838

Published: 2023

Journal Articles

C-CAR039, a Novel Anti-CD20/CD19 Bi-Specific CAR T-Cell Therapy Shows Deep and Durable Clinical Benefits in Patients with Relapsed or Refractory (r/r) B-Cell Non-Hodgkin Lymphoma (B-NHL) in Long Term Follow up

Blood (2023) 142 (Supplement 1): 1025.

https://doi.org/10.1182/blood-2023-182817

Published: 2023

Journal Articles

Development of Best-in-Class Gene Editing Therapy for β-Hemoglobinopathies Using Innovative Transformer Base Editor (tBE)

Blood (2023) 142 (Supplement 1): 5243.

https://doi.org/10.1182/blood-2023-178440

Published: 2023

Journal Articles

JAK2 Kinase Fusion and Myeloid Involvement in Acute Lymphoblastic Leukemia

Tong Wang, Jingbo Ni, Xue Chen, Panxiang Cao, Jinan Tan, Hongwei Zhang, Jiangcheng Fang, Xinying Wei, Jiaqi Chen, Xiaoli Ma, Yang Zhang, Fang Wang, Yan Zhang, Yan Dai, Hongxing Liu

Blood (2023) 142 (Supplement 1): 4348.

https://doi.org/10.1182/blood-2023-181682

Published: 2023

Journal Articles

Multiplex Genome Editing of Human T Cells with Innovative Transformer Base Editor (tBE) for Construction of Next Generation CAR-T Therapies

Peixue Li, Qing Su, Ya Xu, Jing He, Lijie Wang, Yichuan Wang, Huanyu Li, Kewei Lan, Huiming Zheng, Di Zhu, Yan Zhang, Runni Guo, Hongxia Ma, Lang Zhang, Yuchen Zhang, Runze Gao, Bingbing Wu, Susan Mou, Jia Chen

Blood (2023) 142 (Supplement 1): 6825.

https://doi.org/10.1182/blood-2023-178504

Published: 2023

Journal Articles

Multiple-Factor Analysis of Human Herpes Virus 6 Infection in Complementary Transplantation with Haploidentical Stem Cells and Unrelated Cord Blood

Chaoke Bu, Zhongxing Feng, Nan Liu, Yan Zhang, Chunfu Li

Blood (2023) 142 (Supplement 1): 6982.

https://doi.org/10.1182/blood-2023-181050

Published: 2023

Journal Articles

A phase 2 prospective study of bortezomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed iMCD

Hao Zhao, Miao-yan Zhang, Kai-ni Shen, Jun Feng, Xin-xin Cao, Ming-hui Duan, Dao-bin Zhou, Lu Zhang, Jian Li

Blood (2023) 141 (21): 2654–2657.

https://doi.org/10.1182/blood.2023020009

Published: 2023

Includes: Supplemental data

NARROW

Multicenter Real-World Use of Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma(DLBCL) of Frontline and Relapse/Refractory Settings in China

Chemo-Free Salvage Treatment Is Better Than Traditional Chemotherapy in Relapsed/Refractory Subcutaneous Panniculitis-like T-Cell Lymphoma

CHOP Is Insufficient for Newly-Diagnosed Subcutaneous Panniculitis-like T-Cell Lymphoma Patients: A Retrospective Study of 32 Patients in China

A Novel Direct Hemoglobin S Polymerization Inhibitor for the Treatment of Sickle Cell Disease - In Vivo Efficacy of Ilx-002 in Humanized Mice

Rapid, Efficient and Durable Fetal Hemoglobin Production Following CS-101 Treatment in Transfusion-Dependent β-Thalassemia Participants: An Autologous, Ex Vivo Edited CD34+ Stem Cell Product Using the Innovative Transformer Base Editor (tBE)

Polatuzumab Vedotin, Rituximab and Lenalidomide (Pola-R 2 ) As First-Line Therapy for Unfit and Frail Elderly Diffuse Large B-Cell Lymphoma Patients: Preliminary Result of a Prospective, Phase II, Multi-Center Study

The Clinical Characteristics and Prognostic Analysis of Prolonged Cytopenia after CAR-T Cell Therapy

Prediction of Organs Toxicity during CAR T-Cell Therapy By Using Cell-Free DNA Markers

Safety and Efficacy in Patients with Advanced Lymphomas from a Global Phase 1a/1b, First-in-Human Study of CS5001, a Novel Anti-ROR1 ADC

MBS314, a G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) x B-Cell Maturation Antigen (BCMA) x CD3 Trispecific Antibody, in Relapsed and/or Refractory Multiple Myeloma (RRMM): Preliminary Results from a Phase Ⅰ, First-in-Human, Open-Label, Dose Escalation Study

Inhibition of TGF-β in Bone Marrow Endothelial Progenitor Cells Promotes Hematopoietic Recovery in Acute Myeloid Leukemia after Chemotherapy

Foxo1 is an iron-responsive transcriptional factor regulating systemic iron homeostasis

T/B MPAL with MLLT10 :: ASUN fusion

VLA-4 Agonist Enhances the Capacity of HSC Engraftment and Immune Reconstitution

C-CAR039, a Novel Anti-CD20/CD19 Bi-Specific CAR T-Cell Therapy Shows Deep and Durable Clinical Benefits in Patients with Relapsed or Refractory (r/r) B-Cell Non-Hodgkin Lymphoma (B-NHL) in Long Term Follow up

Development of Best-in-Class Gene Editing Therapy for β-Hemoglobinopathies Using Innovative Transformer Base Editor (tBE)

JAK2 Kinase Fusion and Myeloid Involvement in Acute Lymphoblastic Leukemia

Multiplex Genome Editing of Human T Cells with Innovative Transformer Base Editor (tBE) for Construction of Next Generation CAR-T Therapies

Multiple-Factor Analysis of Human Herpes Virus 6 Infection in Complementary Transplantation with Haploidentical Stem Cells and Unrelated Cord Blood

A phase 2 prospective study of bortezomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed iMCD

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only